CBD Oil Products Advertising May Make False Claims About Effectiveness, Contents

Companies that sell CBD oil products typically market them as pure or the “real deal,” but in reality, these products vary widely in quality. Many consumers are unaware of the extent to which the CBD products they buy are regulated, of how much actual CBD is in those products, and even of how psychoactive CBD is.

Indeed, CBD, or cannabidiol, is often confused with THC, but CBD is non-psychoactive—that is, it doesn’t create a “high” for users. The cannabis-derived chemical is largely unregulated, but these products are showing up everywhere. You can buy CBD products in department stores, pharmacies, and even your local coffee shop.

According to a recent survey conducted by the Grocery Manufacturers Association, about 34 percent of Americans have purchased products infused with CBD. However, 76 percent of Americans assumed that the federal government has some form of regulation over the products. This is not the case—there is currently no federal regulation on CBD-based products.

Despite the major misconceptions the average American has about CBD oil products, they are growing increasingly popular. In fact, growth in popularity of CBD products is astronomical. The year over year increase between 2018 and 2019 is estimated to reach about 706 percent, to about $5 billion, reports the Brightfield Group.

Some products advertised as containing CBD may not actually contain as much as they indicate, however. “The very first thing would be to see if they actually state what the CBD concentration is, how many milligrams are in the product,” says Dr. Andrew Kerklaan, a chiropractor who also studies CBD. “If you can’t find that anywhere, then I would be suspicious as to how much [CBD] it had, and whether it even had any.”

CBD products are often used and even actively marketed as methods of treating a variety of problems like pain, inflammation, skin disorders, anxiety, depression, neurological problems, epilepsy, and PTSD. However, the U.S. Food and Drug Administration (FDA) has issued a warning over marketing CBD products as capable of treating cancer, Alzheimer’s, opioid withdrawal, pain, and even pet anxiety.

According to the FDA, “Selling unapproved products with unsubstantiated therapeutic claims—such as claims that CBD products can treat serious diseases and conditions—can put patients and consumers at risk by leading them to put off important medical care. Additionally, there are many unanswered questions about the science, safety effectiveness and quality of unapproved products containing CBD.”

Indeed, so far, epilepsy treatment is the only medical condition for which CBD has been found to have significant evidence supporting its viability according to the FDA.

Several companies are currently being investigated for potentially making false claims about their CBD products, including the following:

• Avid Hemp Gummies
• Freedom Wellness
• Heady Harvest Gummies
• Puur CBD Vape Cartridge

A full list of the companies being investigated can be found on our investigation page.

If you have purchased CBD products from these or other companies, you may have been affected by false claims regarding the amount of its active ingredient actually included in the product, or about the effectiveness of the product for treating certain medical problems. You may be able to join this class action lawsuit investigation.

Join a Free CBD Supplements Class Action Lawsuit Investigation

If you purchased a CBD supplement, it may have contained far less of the active ingredient that you were led to believe, and you may qualify to join this CBD supplement class action lawsuit investigation.

Get a Free Case Evaluation Now

This article is not legal advice. It is presented
for informational purposes only.